The trademark application SILVERBACK THERAPEUTICS was filed by Silverback Therapeutics, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on May 30, 2021, and it was registered by office on September 6, 2021 without any oppositions.
The application was filed in Dutch (English was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Therapeutics
Therapeutic products for the treatment of human diseases
Biopharmaceuticals
Pharmaceuticals
Pharmaceutical preparations
Biologics
Pharmaceuticals, pharmaceutical preparations, agents, molecules, therapies and medicines for use in the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases.
The mark was filed in class 42 with following description of goods:
Pharmaceutical and therapeutics research and development services
Research, development and testing in the therapeutics, pharmaceutical, biopharmaceutical, and biotechnology fields
Research and product development in the field of human therapeutics
Providing a website featuring research and development information in the therapeutics, pharmaceutical, biopharmaceutical and biotechnology fields
Research services using a platform of biological research tools and techniques for use in the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases
Pharmaceutical product development
Clinical trials
Scientific research and development services in connection to medical and pharmaceutical products and services as well as biotechnology
Provision of information relating to pharmaceuticals, therapeutics, biopharmaceuticals and biotechnology.